{"id":"W2987248752","doi":"10.1016/s1473-3099(19)30312-3","title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","year":2019,"lang":"en","type":"review","venue":"The Lancet Infectious Diseases","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1756,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"National Institute of Allergy and Infectious Diseases; European Research Council; Deutsche Gesellschaft für Epileptologie; Basilea Pharmaceutica; Astellas Pharma; Agenzia Spaziale Italiana; Teva Pharmaceutical Industries; Meso Scale Diagnostics; Les Laboratories Pierre Fabre; Deutsches Zentrum für Infektionsforschung; University of Leeds; Roche; Charitable Leadership Foundation; AstraZeneca; Chiesi Farmaceutici; GlaxoSmithKline Australia; European Commission; Bundesministerium für Bildung und Forschung; Merck KGaA; Bayer; Gilead Sciences; Deutsches Zentrum für Lungenforschung; 3M; Pfizer; Covidien; Physicians' Services Incorporated Foundation; Novartis","keywords":"Mucormycosis; Guideline; Posaconazole; Medicine; Disease; Intervention (counseling); Intensive care medicine; Amphotericin B; Multidisciplinary approach; Medical mycology; Surgery; Antifungal; Pathology; Dermatology; Political science","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}